An estimated 24 million Americans will use these weight loss drugs by 2035, posing significant challenges as well as ...

Joey Gonzalez, global co-CEO of Barry’s, joins CNBC to discuss outlooks on fitness in the era of GLP-1 drugs, trends in gym ...

Losing weight by dieting (restricting energy) includes, along with fat loss, losing lean mass, about half of which is ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

Kwame Raoul’s office sent cease and desist letters to five unnamed medical spas in the Chicago area that were allegedly ...

Jessica Alba shared new family pics with husband Cash Warren days after sparking rumors of marital strife. Jessica Klepser, ...

Seeking Alpha analyst Terry Chrisomalis regards Viking Therapeutics as the most attractive M&A candidate in 2025, bolstered ...

JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.

Eighty percent of doctors in a Medscape survey answered no when asked, “Is enough known about obesity meds’ risk to ...

I found that so many people were making their own GLP-1s and taking smaller amounts than normally prescribed,” she said. “I ...